M&T Bank Corp Crispr Therapeutics Ag Transaction History

M&T Bank Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$110.72 - $210.04 $369,140 - $700,273	-3,334 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$79.67 - $173.23 $405,440 - $881,567	-5,089 Reduced 60.42%	3,334 $510,000
Q2 2020 Jul 29, 2020	BUY	$38.5 - $76.05 $12,089 - $23,879	314 Added 3.87%	8,423 $619,000
Q3 2019 Nov 12, 2019	SELL	$40.99 - $52.56 $4,099 - $5,256	-100 Reduced 1.22%	8,109 $332,000
Q1 2019 May 15, 2019	BUY	$28.02 - $40.87 $230,016 - $335,501	8,209 New	8,209 $294,000
Q3 2018 Nov 09, 2018	SELL	$44.35 - $65.71 $196,914 - $291,752	-4,440 Closed	0 $0
Q2 2018 Aug 10, 2018	BUY	$42.62 - $73.59 $426 - $735	10 Added 0.23%	4,440 $261,000
Q1 2018 May 04, 2018	BUY	$23.52 - $58.17 $104,193 - $257,693	4,430 New	4,430 $202,000

491

58M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.74B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of M&T Bank Corp, based on Form 13F filings with the SEC.

Stay updated on M&T Bank Corp with notifications on news.